Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria

被引:12
|
作者
Kim, Ji-Hye [1 ]
Lee, Hyung-Young [1 ]
Ban, Ga-Young [1 ]
Shin, Yoo-Seob [1 ]
Park, Hae-Sim [1 ]
Ye, Young-Min [1 ]
机构
[1] Ajou Univ, Sch Med, Dept Allergy & Clin Immunol, 164 Worldcup Ro, Suwon 443721, South Korea
基金
新加坡国家研究基金会;
关键词
OXIDATIVE STRESS; APOLIPOPROTEIN J/CLUSTERIN; MAST-CELLS; BIOMARKER; EXPRESSION; PARAMETERS; MANAGEMENT; DIAGNOSIS; CHAPERONE; SEVERITY;
D O I
10.1097/MD.0000000000003688
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A substantial proportion of patients with chronic spontaneous urticaria (CSU) are refractory to antihistamines. However, identifying the subpopulation whose urticaria is not completely controlled by antihistamines remains difficult. The response of autologous serum skin test (ASST), a clinical test for the detection of basophil histamine-releasing activity upon autoantibodies or autoreactive stimulation, has been suggested as a potential predictor in the control of urticaria. We sought to identify proteins that were differentially expressed in the sera of patients with positive and negative ASST results and to investigate their association with urticaria control.Proteomics analysis was performed using sera from 3 CSU patients with positive ASST results compared with those showing negative ASST results. Seven upregulated and 5 downregulated proteins were identified by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in the ASST-positive group compared with the ASST-negative group.Proteins that were differentially expressed according to the ASST results in CSU patients were classified into 6 groups: apolipoproteins, glycoproteins, modified albumin, haptoglobulin, plectin, and others. Among these, apolipoprotein J or clusterin was validated using an enzyme-linked immunosorbent assay. Clusterin levels in 69 ASST-positive patients were significantly higher than those in 69 ASST-negative patients and in 86 healthy controls (231.2 +/- 44.0 vs 210.2 +/- 36.1 vs 118.7 +/- 71.9g/mL, P<0.001). Furthermore, clusterin levels differed significantly between patients with responsive and refractory responses to antihistamine treatment within 3 months (231.0 +/- 39.1 vs 205.1 +/- 40.4g/mL, P<0.001). ASST results and serum clusterin levels can predict 92.7% of CSU patients whose urticaria would be refractory to antihistamines. Serum clusterin can be a prognostic marker to determine the responsiveness to antihistamine treatment in patients with CSU.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Analysis of procalcitonin and CRP concentrations in serum of patients with chronic spontaneous urticaria
    Kasperska-Zajac, A.
    Grzanka, A.
    Machura, E.
    Mazur, B.
    Misiolek, M.
    Czecior, E.
    Kasperski, J.
    Jochem, J.
    INFLAMMATION RESEARCH, 2013, 62 (03) : 309 - 312
  • [22] Increased levels of serum IL-31 in chronic spontaneous urticaria*
    Raap, Ulrike
    Wieczorek, Dorothea
    Gehring, Manuela
    Pauls, Inga
    Staender, Sonja
    Kapp, Alexander
    Wedi, Bettina
    EXPERIMENTAL DERMATOLOGY, 2010, 19 (05) : 464 - 466
  • [23] Assessment of Serum Zonulin Levels in Individuals Diagnosed With Chronic Spontaneous Urticaria
    Unal, Alkim
    Ulfer, Gozde
    ANNALS OF DERMATOLOGY, 2024, 36 (04) : 231 - 235
  • [24] Decreased Serum Vitamin D Level In Patients With Chronic Spontaneous Urticaria
    Boonpiyathad, Tadech
    Pradappongsa, Panitan
    Sangasapaviriya, Atik
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB120 - AB120
  • [25] Chronic spontaneous urticaria: Autologous serum skin screening test and autologous serum therapy
    Bhatia, Jushya
    Bhatia, Kailash
    Parekh, Niyati
    Dayal, Satgur
    Kataria, Rajesh
    Namdeo, Chaitanya
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB70 - AB70
  • [26] Analysis of procalcitonin and CRP concentrations in serum of patients with chronic spontaneous urticaria
    A. Kasperska-Zajac
    A. Grzanka
    E. Machura
    B. Mazur
    M. Misiolek
    E. Czecior
    J. Kasperski
    J. Jochem
    Inflammation Research, 2013, 62 : 309 - 312
  • [27] Benralizumab for Chronic Spontaneous Urticaria
    Bernstein, Jonathan A.
    Singh, Umesh
    Rao, Marepalli B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (14): : 1389 - 1391
  • [28] Ligelizumab for Chronic Spontaneous Urticaria
    Maurer, Marcus
    Gimenez-Arnau, Ana M.
    Sussman, Gordon
    Metz, Martin
    Baker, Diane R.
    Bauer, Andrea
    Bernstein, Jonathan A.
    Brehler, Randolf
    Chu, Chia-Yu
    Chung, Wen-Hung
    Danilycheva, Inna
    Grattan, Clive
    Hebert, Jacques
    Katelaris, Constance
    Makris, Michael
    Meshkova, Raisa
    Savic, Sinisa
    Sinclair, Rodney
    Sitz, Karl
    Staubach, Petra
    Wedi, Bettina
    Loeffler, Juergen
    Barve, Avantika
    Kobayashi, Kenneth
    Hua, Eva
    Severin, Thomas
    Janocha, Reinhold
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (14): : 1321 - 1332
  • [29] Omalizumab in chronic spontaneous urticaria
    Martin Marques, Marta
    De Dios Lopez, Anna
    Jornet Montana, Sonia
    Sanchez Parada, Lucia
    Lopez Broseta, Pilar Ana
    del Estal Jimenez, Jorge
    Canela Subirada, Montserrat
    Canadell Vilarrasa, Laura
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 223 - 223
  • [30] Acupuncture for Chronic Spontaneous Urticaria
    Cummings, Mike
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (12) : 1674 - 1675